Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Statistics from DESeq2</p>

Saved in:

書目詳細資料
主要作者:	Alyssa C. Flint (16676029) (author)
其他作者:	Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
出版:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

_version_	1849927632436592640
author	Alyssa C. Flint (16676029)
author2	Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author
author_facet	Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
author_role	author
dc.creator.none.fl_str_mv	Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
dc.date.none.fl_str_mv	2025-11-25T13:24:23Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30708760
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
dc.title.none.fl_str_mv	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Statistics from DESeq2</p>
eu_rights_str_mv	openAccess
id	Manara_7732ff6e312405125d2246fc1d7b7b7c
identifier_str_mv	10.1158/1078-0432.30708760
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30708760
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C. Flint (16676029)Dana K. Mitchell (16676032)Steven P. Angus (15084264)Abbi E. Smith (16676035)Waylan Bessler (16676038)Li Jiang (16676041)Henry Mang (15293185)Xiaohong Li (16676044)Qingbo Lu (16676047)Brooke Rodriguez (16676050)George E. Sandusky (16676053)Andi R. Masters (16676056)Chi Zhang (15084270)Pengtao Dang (16676059)Jenna Koenig (16676062)Gary L. Johnson (15081520)Weihua Shen (16676065)Jiangang Liu (15018711)Amit Aggarwal (16610489)Gregory P. Donoho (16676068)Melinda D. Willard (16676071)Shripad V. Bhagwat (16676074)D. Wade Clapp (16676077)Steven D. Rhodes (16676080)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyCell CycleCDKs and CDK inhibitorsChemotherapyCombination chemotherapyGene TechnologiesHigh-throughput sequencingPreclinical ModelsAnimal models of cancerProteomicsRare CancersTranslational Research<p>Statistics from DESeq2</p>2025-11-25T13:24:23ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708760https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307087602025-11-25T13:24:23Z
spellingShingle	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma Alyssa C. Flint (16676029) Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
status_str	publishedVersion
title	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_fullStr	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full_unstemmed	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_short	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_sort	Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
topic	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

相似書籍